CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Adams Brian Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +73,220 | 73,220 | ||
| 2023-01-17 | Bergstrom Donald A President, R&D | Grant or award | +160,390 | 246,276 | ||
| 2023-01-17 | Bergstrom Donald A President, R&D | Grant or award · Stock Option (Right to Buy) | +160,390 | 160,390 | ||
| 2023-01-17 | Bergstrom Donald A President, R&D | Grant or award · Stock Option (Right to Buy) | +160,390 | 160,390 | ||
| 2023-01-12 | Adams Brian Chief Legal Officer | Sale | −9,994 | $20.00 | $200K | 51,531 |
| 2022-12-27 | Catinazzo Thomas Chief Financial Officer | Sale | −445 | $14.49 | $6K | 50,231 |
| 2022-12-27 | Bergstrom Donald A President, R&D | Sale | −980 | $14.49 | $14K | 85,886 |
| 2022-12-27 | Adams Brian Chief Legal Officer | Sale | −295 | $14.49 | $4K | 61,525 |
| 2022-11-10 | Patel Sanjiv President and CEO | Option exercise | +18,175 | $4.12 | $75K | 272,729 |
| 2022-11-10 | Patel Sanjiv President and CEO | Sale | −18,175 | $20.00 | $364K | 254,554 |
| 2022-11-10 | Patel Sanjiv President and CEO | Option exercise | +9,825 | $5.04 | $50K | 264,379 |
| 2022-11-10 | Patel Sanjiv President and CEO | Sale | −9,825 | $20.00 | $197K | 254,554 |
| 2022-11-10 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −18,175 | 0 | ||
| 2022-11-10 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −9,825 | 694,779 | ||
| 2022-11-08 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-11-08 | Patel Sanjiv President and CEO | Sale | −14,000 | $20.18 | $283K | 254,554 |
| 2022-11-08 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 18,175 | ||
| 2022-11-01 | Bergstrom Donald A President, R&D | Option exercise | +8,000 | $4.12 | $33K | 94,866 |
| 2022-11-01 | Bergstrom Donald A President, R&D | Sale | −8,000 | $22.75 | $182K | 86,866 |
| 2022-11-01 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −8,000 | 93,456 |
Page 15 of 17 · 329 trades